1. Home
  2. ECO vs HTFL Comparison

ECO vs HTFL Comparison

Compare ECO & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okeanis Eco Tankers Corp.

ECO

Okeanis Eco Tankers Corp.

HOLD

Current Price

$54.59

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

HTFL

Heartflow Inc.

HOLD

Current Price

$26.78

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECO
HTFL
Founded
2018
2007
Country
Greece
United States
Employees
N/A
843
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ECO
HTFL
Price
$54.59
$26.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$42.00
$38.20
AVG Volume (30 Days)
467.3K
2.1M
Earning Date
05-13-2026
05-14-2026
Dividend Yield
6.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.07
$27.66
Revenue Next Year
N/A
$23.55
P/E Ratio
$18.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.38
$20.13
52 Week High
$58.45
$41.22

Technical Indicators

Market Signals
Indicator
ECO
HTFL
Relative Strength Index (RSI) 56.56 39.35
Support Level $48.27 $24.77
Resistance Level $57.47 $32.69
Average True Range (ATR) 2.28 2.33
MACD 0.29 -0.82
Stochastic Oscillator 74.55 8.73

Price Performance

Historical Comparison
ECO
HTFL

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: